Edap Tms’ (EDAP) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Edap Tms S.A. (NASDAQ:EDAP) in a research note published on Monday morning. They currently have a $6.50 price target on the medical equipment provider’s stock.

A number of other research firms have also commented on EDAP. ValuEngine raised shares of Edap Tms from a sell rating to a hold rating in a research report on Friday. Zacks Investment Research lowered shares of Edap Tms from a strong-buy rating to a hold rating in a report on Monday, July 24th.

Shares of Edap Tms (NASDAQ EDAP) opened at 3.188 on Monday. The company has a 50-day moving average of $2.95 and a 200-day moving average of $2.92. Edap Tms has a 1-year low of $2.25 and a 1-year high of $3.85. The company’s market cap is $92.44 million.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). Edap Tms had a positive return on equity of 10.31% and a negative net margin of 0.27%. The business had revenue of $10.40 million for the quarter, compared to the consensus estimate of $10.00 million. During the same period in the prior year, the business posted $0.10 earnings per share. Edap Tms’s revenue was up 13.0% compared to the same quarter last year. Equities analysts forecast that Edap Tms will post $0.01 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Edap Tms’ (EDAP) Buy Rating Reaffirmed at HC Wainwright” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://ledgergazette.com/2017/10/10/edap-tms-edap-buy-rating-reaffirmed-at-hc-wainwright.html.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Archon Capital Management LLC acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $2,474,000. Hilton Capital Management LLC increased its stake in shares of Edap Tms by 43.1% in the 2nd quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after acquiring an additional 25,000 shares in the last quarter. Essex Investment Management Co. LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at $172,000. Finally, Virtu KCG Holdings LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at $117,000. Hedge funds and other institutional investors own 9.41% of the company’s stock.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in

A number of other research firms have also commented on EDAP. ValuEngine raised shares of Edap Tms from a sell rating to a hold rating in a research report on Friday. Zacks Investment Research lowered shares of Edap Tms from a strong-buy rating to a hold rating in a report on Monday, July 24th.

Shares of Edap Tms (NASDAQ EDAP) opened at 3.188 on Monday. The company has a 50-day moving average of $2.95 and a 200-day moving average of $2.92. Edap Tms has a 1-year low of $2.25 and a 1-year high of $3.85. The company’s market cap is $92.44 million.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings results on Wednesday, August 23rd. The medical equipment provider reported ($0.05) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.03). Edap Tms had a positive return on equity of 10.31% and a negative net margin of 0.27%. The business had revenue of $10.40 million for the quarter, compared to the consensus estimate of $10.00 million. During the same period in the prior year, the business posted $0.10 earnings per share. Edap Tms’s revenue was up 13.0% compared to the same quarter last year. Equities analysts forecast that Edap Tms will post $0.01 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Edap Tms’ (EDAP) Buy Rating Reaffirmed at HC Wainwright” was originally published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://ledgergazette.com/2017/10/10/edap-tms-edap-buy-rating-reaffirmed-at-hc-wainwright.html.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Archon Capital Management LLC acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $2,474,000. Hilton Capital Management LLC increased its stake in shares of Edap Tms by 43.1% in the 2nd quarter. Hilton Capital Management LLC now owns 83,000 shares of the medical equipment provider’s stock valued at $274,000 after acquiring an additional 25,000 shares in the last quarter. Essex Investment Management Co. LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at $172,000. Finally, Virtu KCG Holdings LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at $117,000. Hedge funds and other institutional investors own 9.41% of the company’s stock.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply